Skip to content

The (cost-)effectiveness of a combined lifestyle intervention in overweight and obese patients with knee osteoarthritis in primary care

The (cost-)effectiveness of a combined lifestyle intervention in overweight and obese patients with knee osteoarthritis in primary care - Lifestyle and knee OA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54019
Enrollment
234
Registered
2021-04-01
Start date
2021-07-05
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

All patients will receive usual care by their GP following the NHG guideline non-traumatic knee complaints. This includes advice for regular physical activity (at least 30 minutes a day) and advice

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: o First presentation at GP of knee complaints within previous 24 months o Aged between 45 and 70 years o NICE guideline diagnosis of clinical knee OA (i.e. aged 45 or over and activity related joint pain and either no morning joint-related stiffness or morning stiffness that lasts no longer than 30 minutes) o Presence of overweight or obesity (BMI >=25 kg/m2)

Exclusion criteria

Exclusion criteria: o Other pathological conditions that could explain the joint complaints like traumatic onset knee complaints or presence of other forms of arthritis (rheumatoid arthritis, psoriatic arthritis) or pre-patellar bursitis or patellar tendinitis o Any lower extremity condition other than knee OA resulting in physical impairment that will limit GLI participation. o Contraindications for MRI o Previously participated in a GLI. o Inability to understand the Dutch language

Design outcomes

Primary

MeasureTime frame
5kg or 5% weight reduction after 24 months

Secondary

MeasureTime frame
Secondary study parameters/endpoints 1. Clinical progression of knee OA: decrease in monthly mean pain intensity (11-point NRS) over last 12-months of follow-up 2. Structural progression of knee OA on MRI after 24 months, using our recently introduced definitions for longitudinal evaluation of OA MRI features For cost-effectiveness: 1. Societal costs over 24 months, using the medical consumption and productivity cost questionnaire (Medical Consumption Questionnaire (iMCQ) and iPCQ questionnaires). 2. Quality of life after 24 months (EQ-5D-5L) Other study parameters 1. Other disease specific PROMS (subscales KOOS questionnaire, PASS, GROC) 2. Other health outcomes including HbA1c level (mmol/L), cholesterol (mmol/L), blood pressure, and intestinal microbiota after 24 month follow-up 3. Psychosocial health outcomes in terms of kinesiophobia and self-efficacy for exercise Qualitative interviews 4. (Gender- and sex-specific) Barriers and facilitators of patients for the implementation of the GLI for patients with KOA. Primary mediators that will be investigated on structural and clinical progression of knee OA: - Change in BMI during the first 18-months of follow-up - Meniscal extrusion using two-dimensional quantitative measurements - Biomarkers - Inflammatory markers including IL-6 and CRP - Effusion, using MOAKS scoring[23], on MRI

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026